This inventor holds 4 USPTO granted patents. Top assignee: Monsanto Company. Active years: 1990-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1993
Title: H Eser Tolunay: Innovator in Modified Tissue Plasminogen Activators
Introduction
H Eser Tolunay is a notable inventor based in Creve Coeur, MO (US). He has made significant contributions to the field of biochemistry, particularly in the development of modified tissue plasminogen activators. With a total of 4 patents to his name, Tolunay's work has the potential to impact medical treatments significantly.
Latest Patents
Tolunay's latest patents include innovative modifications to tissue plasminogen activators. One of his notable inventions is a modified t-PA that features an improved in vivo half-life. This invention comprises a fibronectin finger-like domain F, a growth factor domain GF, a sequence of two K2 kringle regions, and a serine protease region SP. In this design, the first kringle is free of any glycosylation site, while the second kringle contains a single glycosylation site. Another significant patent is the modified tissue plasminogen activator K2K2SP, which also boasts an improved in vivo half-life and consists of two K2 kringle regions followed by a serine protease region SP.
Career Highlights
Tolunay is currently employed at Monsanto Company, where he continues to innovate and develop new solutions in his field. His work at Monsanto has allowed him to collaborate with other talented professionals and contribute to groundbreaking research.
Collaborations
Some of Tolunay's coworkers include Leslie D Bell and Ernest J Mayer. Their collaboration has likely fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
H Eser Tolunay is a distinguished inventor whose work in modified tissue plasminogen activators showcases his expertise and dedication to improving medical treatments. His contributions are paving the way for future innovations in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile